LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 72 filers reported holding LEAP THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,442 | -1.3% | 13,064 | +30.6% | 0.00% | – |
| Q4 2022 | $4,500 | +350.0% | 10,000 | +1464.9% | 0.00% | – |
| Q2 2022 | $1,000 | -96.2% | 639 | -95.7% | 0.00% | – |
| Q1 2022 | $26,000 | -18.8% | 14,929 | +50.9% | 0.00% | – |
| Q4 2021 | $32,000 | -40.7% | 9,891 | -26.8% | 0.00% | – |
| Q3 2021 | $54,000 | +390.9% | 13,515 | +93.1% | 0.00% | – |
| Q2 2021 | $11,000 | -15.4% | 7,000 | 0.0% | 0.00% | – |
| Q1 2021 | $13,000 | +18.2% | 7,000 | +54.6% | 0.00% | – |
| Q4 2020 | $11,000 | +175.0% | 4,529 | +126.4% | 0.00% | – |
| Q3 2020 | $4,000 | +33.3% | 2,000 | -29.0% | 0.00% | – |
| Q3 2019 | $3,000 | 0.0% | 2,818 | +79.6% | 0.00% | – |
| Q1 2019 | $3,000 | -78.6% | 1,569 | -10.3% | 0.00% | – |
| Q3 2018 | $14,000 | +16.7% | 1,750 | +33.2% | 0.00% | – |
| Q2 2018 | $12,000 | -25.0% | 1,314 | -31.7% | 0.00% | – |
| Q1 2018 | $16,000 | +14.3% | 1,923 | -12.9% | 0.00% | – |
| Q4 2017 | $14,000 | +100.0% | 2,209 | +85.8% | 0.00% | – |
| Q3 2017 | $7,000 | – | 1,189 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 900,733 | $1,883,000 | 1.44% |
| Sio Capital Management, LLC | 1,501,998 | $3,139,000 | 0.92% |
| CVI Holdings, LLC | 704,900 | $1,473,000 | 0.55% |
| Perceptive Advisors | 8,476,496 | $17,466,000 | 0.28% |
| Artal Group S.A. | 2,974,000 | $6,216,000 | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 880,000 | $1,839,000 | 0.17% |
| DAFNA Capital Management LLC | 275,000 | $575,000 | 0.17% |
| J. Goldman & Co LP | 1,018,285 | $2,128,000 | 0.13% |
| MYDA Advisors LLC | 100,000 | $209,000 | 0.13% |
| 683 Capital Management, LLC | 526,466 | $1,100,000 | 0.09% |